Journal of Nuclear Medicine

Services claiming to be JNM are soliciting authors, editors, and reviewers. Read more to protect yourself.

IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies
Open Access Impact of Radioactive Iodine Treatment on Long-Term Relative Survival in Patients with Papillary and Follicular Thyroid Cancer: A SEER-Based Study Covering Histologic Subtypes and Recurrence Risk Categories
JNM Podcast Episode 10 – Understanding Metabolic PET Markers Beyond SUV
Entities are misrepresenting themselves as JNM. Read more on how to protect yourself.

Published Ahead of Print

Open Access
Semiquantitative PET Parameters Refine Prognosis in CAR T–Treated Lymphoma After 1 and 3 Months: A Prospective Single-Center Study
Andrea Farolfi, Beatrice Casadei, Claudio Malizia, Riccardo Ussia, Veronica Rocchi, Andrea Paccagnella, Marianna Gentilini, Cristina Nanni, Lisa Argnani, Pier Luigi Zinzani and Stefano Fanti

Journal of Nuclear Medicine April 17, 2025, jnumed.125.269670; DOI: https://doi.org/10.2967/jnumed.125.269670
Open Access
[¹⁸F]Florzolotau PET for the Differential Diagnosis of Parkinsonism in Patients with Suspected 4-Repeat Tauopathies
Joachim Brumberg, Nils Schröter, Ganna Blazhenets, M. Aymen Omrane, Christian Volz, Cornelius Weiller, Michel Rijntjes, Lars Frings, Sabine Hellwig, Wolfgang H. Jost and Philipp T. Meyer

Journal of Nuclear Medicine April 17, 2025, jnumed.124.268956; DOI: https://doi.org/10.2967/jnumed.124.268956
You have access
Is Long–Axial-Field-of-View PET/CT Cost-Effective? An International Health–Economic Analysis
Ian Alberts, Stuart More, Karen Knapp, Riccardo Mei, Stefano Fanti, Clemens Mingels, Lorenzo Nardo, Nii Boye Hammond, Harish Nagaraj, Axel Rominger, Gary J.R. Cook and Don Wilson

Journal of Nuclear Medicine April 17, 2025, jnumed.124.269203; DOI: https://doi.org/10.2967/jnumed.124.269203
You have access
FDA Approval of ¹⁸F-Flurpiridaz Is for PET: Stepping into a New Area of Myocardial Perfusion Imaging?
Thomas H. Schindler, Timothy M. Bateman, Daniel S. Berman, Panithaya Chareonthaitawee, Lorraine E. De Blanche, Vasken Dilsizian, Sharmila Dorbala, Robert J. Gropler, Leslee L. Shaw, Prem Soman, David E. Winchester, Hein J. Verberne, Sukhjeet Ahuja, Rob Beanlands, Marcelo Di Carli, Venkatesh L. Murthy, Terrence D. Ruddy and Ronald G. Schwartz

Journal of Nuclear Medicine April 17, 2025, jnumed.124.269154; DOI: https://doi.org/10.2967/jnumed.124.269154
You have access
FDA Reconsiders Rules Around Radiation Dosimetry for First-in-Human Studies of Investigational PET Radiopharmaceuticals
Marianna Dakanali, Steven S. Zigler, Sally W. Schwarz, Michael L. Nickels, Reiko Oyama, Henry F. VanBrocklin and Peter J. H. Scott

Journal of Nuclear Medicine April 17, 2025, jnumed.125.269885; DOI: https://doi.org/10.2967/jnumed.125.269885
You have access
Targeting Extra Domain A of Fibronectin to Improve Noninvasive Detection of Triple-Negative Breast Cancer
Justin S. Hachey, Tara D. Viray, Mattia Matasci, Domenico Ravazza, Dario Neri and Jason S. Lewis

Journal of Nuclear Medicine April 17, 2025, jnumed.124.268859; DOI: https://doi.org/10.2967/jnumed.124.268859

Featured Articles

IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies

April 01, 2025
Impact of Radioactive Iodine Treatment on Long-Term Relative Survival in Patients with Papillary...

April 01, 2025
New Approaches in Radiopharmaceutical Development

April 01, 2025
Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better

April 01, 2025
Are FAP Theranostics Really Happening? Will Radiochemistry or Biology Win?

April 01, 2025
From Stabilization to Depletion: Molecular Imaging to Measure Therapeutic Response in ATTR-CA

April 01, 2025
Molecular Imaging of Pulmonary Fibrosis

April 01, 2025
Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools,...

April 01, 2025
Self-Citation Among Highly Cited Nuclear Medicine and Medical Imaging Researchers

April 01, 2025

About The Journal of Nuclear Medicine

The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research.